Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adele Chimento

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Endocrinology|January 23, 2004
Differential expression of steroidogenic factor-1/adrenal 4 binding protein and liver receptor homolog-1 (LRH-1)/fetoprotein transcription factor in the rat testis: LRH-1 as a potential regulator of testicular aromatase expressionVincenzo Pezzi, Rosa Sirianni, Adele Chimento, et al.
The Journal of Clinical Endocrinology and Metabolism|October 18, 2012
Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatmentRosa Sirianni, Fabiana Zolea, Adele Chimento, et al.
Environmental Health Perspectives|December 17, 2008
G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cellsLidia Albanito, Rosamaria Lappano, Antonio Madeo, et al.
Oncotarget|February 1, 2018
GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathwayIvan Casaburi, Paola Avena, Arianna De Luca, et al.
Environmental Health Perspectives|January 24, 2015
Effects of atrazine on estrogen receptor α- and G protein-coupled receptor 30-mediated signaling and proliferation in cancer cells and cancer-associated fibroblastsLidia Albanito, Rosamaria Lappano, Antonio Madeo, et al.
International Journal of Oncology|February 25, 2015
C-MYC modulation induces responsiveness to paclitaxel in adrenocortical cancer cell linesLidia Cerquetti, Camilla Sampaoli, Maria De Salvo, et al.
Journal of Cellular and Molecular Medicine|March 2, 2021
SIRT1 is involved in adrenocortical cancer growth and motilityAdele Chimento, Arianna De Luca, Marta Claudia Nocito, et al.
Molecular Nutrition & Food Research|December 17, 2009
Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activationRosa Sirianni, Adele Chimento, Arianna De Luca, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 3, 2011
Antiproliferative activity of some 1,4-dimethylcarbazoles on cells that express estrogen receptors: part IAnna Caruso, Adele Chimento, Hussein El-Kashef, et al.
International Journal of Molecular Sciences|June 28, 2023
Cdk4 Regulates Glioblastoma Cell Invasion and Stemness and Is Target of a Notch Inhibitor Plus Resveratrol Combined TreatmentFrancesca Giordano, Maria D'Amico, Francesca Ida Montalto, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Endocrinology|January 23, 2004
Differential expression of steroidogenic factor-1/adrenal 4 binding protein and liver receptor homolog-1 (LRH-1)/fetoprotein transcription factor in the rat testis: LRH-1 as a potential regulator of testicular aromatase expressionVincenzo Pezzi, Rosa Sirianni, Adele Chimento, et al.
The Journal of Clinical Endocrinology and Metabolism|October 18, 2012
Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatmentRosa Sirianni, Fabiana Zolea, Adele Chimento, et al.
Environmental Health Perspectives|December 17, 2008
G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cellsLidia Albanito, Rosamaria Lappano, Antonio Madeo, et al.
Oncotarget|February 1, 2018
GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathwayIvan Casaburi, Paola Avena, Arianna De Luca, et al.
Environmental Health Perspectives|January 24, 2015
Effects of atrazine on estrogen receptor α- and G protein-coupled receptor 30-mediated signaling and proliferation in cancer cells and cancer-associated fibroblastsLidia Albanito, Rosamaria Lappano, Antonio Madeo, et al.
International Journal of Oncology|February 25, 2015
C-MYC modulation induces responsiveness to paclitaxel in adrenocortical cancer cell linesLidia Cerquetti, Camilla Sampaoli, Maria De Salvo, et al.
Journal of Cellular and Molecular Medicine|March 2, 2021
SIRT1 is involved in adrenocortical cancer growth and motilityAdele Chimento, Arianna De Luca, Marta Claudia Nocito, et al.
Molecular Nutrition & Food Research|December 17, 2009
Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activationRosa Sirianni, Adele Chimento, Arianna De Luca, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 3, 2011
Antiproliferative activity of some 1,4-dimethylcarbazoles on cells that express estrogen receptors: part IAnna Caruso, Adele Chimento, Hussein El-Kashef, et al.
International Journal of Molecular Sciences|June 28, 2023
Cdk4 Regulates Glioblastoma Cell Invasion and Stemness and Is Target of a Notch Inhibitor Plus Resveratrol Combined TreatmentFrancesca Giordano, Maria D'Amico, Francesca Ida Montalto, et al.
Pageof 6